<DOC>
	<DOC>NCT00089869</DOC>
	<brief_summary>Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa</brief_summary>
	<brief_title>A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Must have a clinical diagnosis of Schizophrenia Must be at least 18 years of age and not older than 55 years of age Must have been stable on a dose of Abilify, Risperdal, Seroquel, or Zyprexa for the past 8 weeks Women of childbearing potential must be using a medically accepted means of contraception Must be able to swallow capsules Has serious health problems other than Schizophrenia Takes an antidepressant for depression Takes insulin for diabetes Have a history of alcohol or drug dependence (except for nicotine and caffeine) within the past 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>